Sanofi EBITDA 2010-2024 | SNY

Sanofi EBITDA for the quarter ending December 31, 2024 was $1.054B, a 23.42% decline year-over-year.

  • Sanofi 2024 EBITDA was 12.1B, a 18.13% decline from 2023.
  • Sanofi 2023 EBITDA was 14.78B, a 3.18% increase from 2022.
  • Sanofi 2022 EBITDA was 14.324B, a 3.72% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Sanofi EBITDA 2010-2024 | SNY

  • Sanofi 2024 EBITDA was 12.1B, a 18.13% decline from 2023.
  • Sanofi 2023 EBITDA was 14.78B, a 3.18% increase from 2022.
  • Sanofi 2022 EBITDA was 14.324B, a 3.72% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$827.9B
Johnson & Johnson (JNJ)$384.4B
Novo Nordisk (NVO)$375.8B
AbbVie (ABBV)$354.6B
Roche Holding AG (RHHBY)$262.5B
Merck (MRK)$221.8B
Novartis AG (NVS)$219.3B
Pfizer (PFE)$146.8B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B